[ad_1] Moderna and Merck released more positive three-year data Monday on their experimental vaccine, given to patients with the most deadly form of skin cancer […]
Continue readingTag: Biotech and Pharmaceuticals
FDA approves Moderna's RSV vaccine for seniors, the company's second-ever product
[ad_1] The FDA has approved Moderna’s RSV vaccine for older adults. Courtesy: Moderna The Food and Drug Administration on Friday approved Moderna’s vaccine for respiratory […]
Continue readingPfizer's drug for advanced lung cancer shows promising long-term trial results
[ad_1] CHICAGO — Pfizer on Friday said its drug for an advanced form of lung cancer showed promising long-term results in a late-stage trial, which […]
Continue readingHealthy Returns: Pfizer, Merck, J&J and more to release cancer drug data at industry conference
[ad_1] Attendees walk through the lobby at the American Society of Clinical Oncology annual meeting in Chicago. Tim Boyle | Bloomberg | Getty Images Think […]
Continue readingTelehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
[ad_1] GLP-1 Supply Tracker from Ro. Courtesy: Ro Telehealth company Ro on Wednesday launched a new tracker to help patients find a popular class of […]
Continue readingHere's how U.S. health officials are responding to bird flu in humans after second case
[ad_1] Cows are seen standing in a feedlot on June 14, 2023 in Quemado, Texas. Brandon Bell | Getty Images U.S. health officials are monitoring […]
Continue readingEli Lilly to invest another $5.3 billion in Indiana plant to expand Mounjaro, Zepbound supply
[ad_1] An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Brendan McDermid | Reuters […]
Continue readingTwo CVS retail stores in Rhode Island join new national pharmacy union
[ad_1] The CVS pharmacy logo is displayed on a sign above a CVS Health Corp. store in Las Vegas, Nevada on Feb. 7, 2024. Patrick […]
Continue readingThis up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A
[ad_1] Skynesher | E+ | Getty Images Big pharma is betting billions on an up-and-coming class of cancer treatments that some on Wall Street are […]
Continue readingA corner of the cancer therapy market is heating up—Here are the names investors need to know
[ad_1] There’s been a lot of attention lately on a corner of the oncology market called radiopharmaceuticals. The therapy seeks to destroy cancer cells by […]
Continue reading